Position in VNDA
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$1,791,470
-$315,345 QoQ
Shares Held
292,724
-4.0% QoQ
Ownership
0.484%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#31
of 172 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 82%
Shared 0%
None 18%
Common Shares in VNDA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026JPMORGAN CHASE & CO holds $12,920,143,201 across 425 Biotechnology names. VNDA ranks #157 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,517,600 | $3,237,487,438 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,774,199 | $2,353,364,036 | |
| 3 | INSM |
INSMED Inc
|
10,428,170 | $1,111,851,478 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,675,517 | $805,410,876 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
3,298,066 | $617,661,794 | |
| 6 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
2,652,746 | $294,534,385 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
1,160,786 | $279,714,596 | |
| 8 | QURE |
uniQure N.V.
|
4,867,755 | $224,208,791 |
All Filings in VNDA
Export CSV
32 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,791,470 | 292,724 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $2,106,815 | 304,894 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $3,492,867 | 396,017 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $997,463 | 199,893 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $810,210 | 171,655 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $1,609,256 | 350,601 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $1,608,197 | 335,741 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $753,783 | 160,722 | Shares | Defined | 2024-12-26 | |
| 2024-06-30 | $782,370 | 138,473 | Shares | Defined | 2024-12-26 | |
| 2024-03-31 | $1,154,016 | 280,783 | Shares | Defined | 2024-12-26 | |
| 2023-12-31 | $869,449 | 206,031 | Shares | Defined | 2024-12-26 | |
| 2023-09-30 | $981,782 | 227,265 | Shares | Other | 2023-11-14 | |
| 2023-06-30 | $867,572 | 131,650 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $1,411,449 | 207,872 | Shares | Defined | 2023-05-18 | |
| 2022-12-31 | $1,635,286 | 221,284 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $1,451,972 | 146,961 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,145,719 | 105,112 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $4,114,214 | 363,768 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $5,445,243 | 347,052 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $5,998,827 | 349,990 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 ALXN | — | 1,748,795 | Shares | Other | 2021-08-12 | |
| 2021-06-30 | $8,041,102 | 373,831 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 ALXN | — | 2,264,381 | Shares | Other | 2021-05-12 | |
| 2021-03-31 | $4,496,206 | 299,348 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 ALXN | — | 4,311,410 | Shares | Other | 2021-02-19 | |
| 2020-12-31 | $4,809,725 | 366,037 | Shares | Defined | 2021-02-19 | |
| 2020-09-30 ALXN | — | 4,199,711 | Shares | Other | 2020-11-12 | |
| 2020-09-30 | $1,358,214 | 140,602 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 ALXN | — | 3,824,816 | Shares | Other | 2020-08-11 | |
| 2020-06-30 | $1,731,397 | 151,346 | Shares | Defined | 2020-08-11 | |
| 2020-03-31 ALXN | — | 2,954,634 | Shares | Defined | 2020-05-12 | |
| 2020-03-31 | $1,783,907 | 172,192 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||